Therapeutic Apheresis and Dialysis (ISSN 1744-9987, 1744-9979) is a journal published by Wiley in the United Kingdom. It covers Medicine, Hematology and Nephrology. It is indexed in Scopus, Web of Science, MEDLINE, PubMed and HEC. Recorded metrics: impact factor 1.5, Scopus Q2, Web of Science Q3, CiteScore 3 and HEC W-Category. Article processing charge: USD 3,700. This profile brings together the journal's ISSN, publisher, country, subject area, HEC category, Scopus data, SJR and SCImago rank, Web of Science data, impact factor, indexing, open access status, APC, aims and scope, about the journal, author instructions, journal website and registration details from the most reputable indexes, in one place.
Therapeutic Apheresis and Dialysis
Record last updated . Check current status at HEC HJRS, Scopus and the Web of Science Master Journal List before submitting. About our data.
Journal lists: Q2 journals · Q3 journals · HEC W category journals · Scopus journals · Web of Science journals · MEDLINE journals · PubMed journals · SCImago journals · SCIE journals · Impact factor journals · Q2 Medicine journals · Q2 Hematology journals
Quick answers about Therapeutic Apheresis and Dialysis
Is Therapeutic Apheresis and Dialysis HEC recognised?
Yes. The catalogue records Therapeutic Apheresis and Dialysis in HEC category W of the HEC Journal Recognition System, where W is the highest and Y the lowest category. Confirm the current category on HEC's HJRS website before you submit.
Is Therapeutic Apheresis and Dialysis indexed in Scopus?
Yes. Therapeutic Apheresis and Dialysis is listed as Scopus-indexed, in quartile Q2, with a CiteScore of 3. Check its current status on the Scopus Sources page.
Is Therapeutic Apheresis and Dialysis in Web of Science?
Yes. Therapeutic Apheresis and Dialysis is listed as a Web of Science journal in the Science Citation Index Expanded (SCIE), with Web of Science quartile Q3. Confirm on Clarivate's Master Journal List.
What is the impact factor of Therapeutic Apheresis and Dialysis?
The recorded journal impact factor of Therapeutic Apheresis and Dialysis is 1.5. Clarivate updates impact factors every year in Journal Citation Reports.
Is Therapeutic Apheresis and Dialysis open access, and what does it charge?
Therapeutic Apheresis and Dialysis is not recorded as fully open access and its APC is USD 3,700. Fees change, so check the journal's website before you submit.
Who publishes Therapeutic Apheresis and Dialysis?
Therapeutic Apheresis and Dialysis is published by Wiley in United Kingdom, under ISSN 1744-9987 and 1744-9979.
Research profile
- 3,799articles indexed
- 45,834citations
- 75h-index
- 1.282-year mean citedness
- 2001first year indexed
Main research topics: Dialysis and Renal Disease Management, Parathyroid Disorders and Treatments, Blood transfusion and management, Central Venous Catheters and Hemodialysis, Acute Kidney Injury Research, Chronic Kidney Disease and Diabetes.
Source: OpenAlex (CC0), retrieved 20 November 2026. Counts cover works OpenAlex has indexed and differ from Scopus and Web of Science.
Browse similar journals
- Medicine journals (8,023)
- Hematology journals (159)
- Nephrology journals (91)
- Journals indexed in Scopus (31,185)
- Journals indexed in Web of Science (22,643)
- Journals indexed in MEDLINE (3,645)
- Journals indexed in PubMed (16,086)
- Journals indexed in HEC (34,823)
- Scopus Q2 journals (8,223)
- Web of Science Q3 journals (5,105)
- HEC W-Category journals (13,616)
- Journals published in the United Kingdom (7,333)
- Wiley journals (1,807)